Downloads

  1. Meet The Latest Member Of The Oligo Synthesis Family 10/30/2025

    Discover a system with a flexible synthesis scale, intuitive software, and robust process control that is ideal for labs moving from research to production.

  2. Developing Your Risk-Based Approach To Single-Use System Integrity 10/29/2025

    Explore how a holistic approach to single-use system integrity can strengthen contamination control, improve operational efficiency, and meet evolving regulatory expectations in manufacturing.

  3. Optimize DNA Clearance In High-Salt, GMP-Grade Purification Processes 10/28/2025

    Explore how salt-active endonucleases overcome DNA clearance challenges in viral vector purification by digesting down to 3–5 nucleotides and performing reliably in high-salt conditions.

  4. How Sethera Harnesses A Promiscuous Enzyme To Make Recombinant Peptides 10/21/2025

    A class of enzymes previously believed to be specific and intolerant of change might actually have broad applicability.

  5. Careful Outsourcing Proves Key To Targeted Protein Degradation Drug Development 10/21/2025

    Discover how partnerships — especially with capable CROs — as well as resilient supply chains, digital enablement, regulatory foresight, and specialized talent impact the success of targeted protein degradation therapies.

  6. How Lipid Nanoparticles Enable Next-Gen Delivery 10/20/2025

    Cell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.

  7. Why Biopharma Breakthroughs Aren't Moving The Market 10/20/2025

    Biopharma is innovating fast but falling short commercially. Reveal key ecosystem gaps and five strategic actions to help strengthen resilience, accelerate performance, and futureproof organizations.

  8. Selective Degradation Of Cancer Target WDR5 10/17/2025

    Explore how to enable precise biophysical characterization of PROTACs targeting WDR5 to help overcome challenges with undruggable cancer proteins and complex interactions.

  9. How To Keep Your Degrader Pipeline Moving Forward 10/17/2025

    Discover a new biophysical method that simplifies PROTAC characterization, improves assay development, and delivers high-quality affinity data even for complex interactions.

  10. 100% U.S. Drug Tariffs: Implications For Pharma And Outsourcing 10/17/2025

    Research Manager Mathini Ilancheran explores the effects of U.S. drug tariffs on global supply chains, multinational pharma firms, and critical partners across drug development.